Study of induction paclitaxel and cisplatin followed by standard radiotherapy vs hyper fractionated radiotherapy and cisplatin as radio sensitizer for patients with unresectable stage IIIA and IIIB non-small cell lung cancer

Brain metastases in non small cell lung cancer (NSCLC) : Retrospective analysis of risk factors and treatment outcome

Continous Hyperfractionated Accelerated Radiotherapy Weekend Less (CHARTWEL) versus conventional radiotherapy combined with cisplatin and vinorelbine in both arms in locally advanced (Stage III) non-small cell lung cancer

Gemcitabine vs cisplatin concurrent with radiation therapy in locally advanced squamous cell carcinoma of head and neck cancer

Comparative study of taxanes versus vinorelibine and 5 FU ASA first therapy inmetastatic breast cancer patients

Prognostic impact of epidermal growth factor receptor (EGFR) mutations in lung cancer

Retrospective study on malignant pleural mesothelioma : Clinical presentation and treatment outcome

The effect of Bisphosphonates on skeletal-relatedevents of metastatic bladder cancer : A controlled randomized study

Evaluation of a new tumour marker in patients with non-small cell lung cancer: CYFRA 21-1

Role of 99mTc-Sestamibi in assessing treatment response in patients with non small cell lung cancer